Cite
MLA Citation
Daniel P Petrylak et al.. “Ramucirumab plus docetaxel versus placebo plus docetaxel in patients with locally advanced or metastatic urothelial carcinoma after platinum-based therapy (RANGE): overall survival and updated results of a randomised, double-blind, phase 3 trial.” Lancet oncology, vol. 21, no. 1, 2020, pp. 105–120. http://access.bl.uk/ark:/81055/vdc_100098645135.0x00001f